Your browser doesn't support javascript.
loading
Protective effects of P2X7 receptor inhibition in cerebral ischemia/reperfusion injury in rats / 中南大学学报(医学版)
Journal of Central South University(Medical Sciences) ; (12): 1169-1176, 2018.
Artigo em Chinês | WPRIM | ID: wpr-813120
ABSTRACT
To investigate the protective effects of P2X7 receptor (P2X7R) inhibitor against cerebral ischemia/reperfusion (I/R) injury in rats and the possible mechanisms.


Methods:

The neurological deficit of rats was evaluated by Longa score. The infarct volume was examined by 2, 3, 5-triphenyltetrazolium chloride (TTC) staining. The expression levels of extracellular signal-regulated kinase (ERK), phosphorylation extracellular signal-regulated kinas p-ERK), connexin 43 (Cx43), Bax, Bcl-2 and cleaved caspase-3 were detected by Western blot.


Results:

Compared with sham group, the neurobehavioral score (P<0.05) and cerebral infarct volume (P<0.01) of rats in I/R group was increased. Compared with I/R group, brilliant blue G (BBG, the antagonist of P2X7R) or PD98059 (the inhibitor of EKR kinase) could reduce the neurobehavioral score (P<0.01) and cerebral infarct volume significantly (P<0.05). The neurobehavioral score and cerebral infarct volume was further decreased (P<0.05) when rats were treated with both BBG and PD98059. Compared with I/R group, the expression levels of p-ERK, Cx43, cleaved caspase-3 and the ratio of Bax/Bcl-2 were decreased by BBG or PD98059 pretreatment, and the protective effects were further enhanced when rats were treated with both BBG and PD98059 (P<0.05).


Conclusion:

Inhibition of P2X7R reduces the cerebral I/R injury of rats. ERK inhibition is probably involved in the protective effects of P2X7R inhibitor against cerebral I/R injury, which may be related to the reduction of Cx43 and cleaved caspase-3, and the ratio of Bax/Bcl-2.
Assuntos
Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Farmacologia / Fosforilação / Traumatismo por Reperfusão / Isquemia Encefálica / Regulação da Expressão Gênica / Usos Terapêuticos / Tratamento Farmacológico / Receptores Purinérgicos P2X7 / Antagonistas do Receptor Purinérgico P2X Limite: Animais Idioma: Chinês Revista: Journal of Central South University(Medical Sciences) Ano de publicação: 2018 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Farmacologia / Fosforilação / Traumatismo por Reperfusão / Isquemia Encefálica / Regulação da Expressão Gênica / Usos Terapêuticos / Tratamento Farmacológico / Receptores Purinérgicos P2X7 / Antagonistas do Receptor Purinérgico P2X Limite: Animais Idioma: Chinês Revista: Journal of Central South University(Medical Sciences) Ano de publicação: 2018 Tipo de documento: Artigo